50 results on '"Porter, Gerard"'
Search Results
2. Undue Influence from the Family in Declining COVID-19 Vaccination and Treatment for the Elderly Patient
3. Pauli Exclusion by n→π* Interactions: Implications for Paleobiology.
4. Genetic Testing, Insurance and Employment in the UK: Is the Regulatory Regime Fit for Purpose?
5. Undue Influence from the Family in Declining COVID-19 Vaccination and Treatment for the Elderly Patient
6. Structure, Organization, and Knowledge Production of Clinical Trial Industry
7. Ethical and Regulatory Challenges with Autologous Adult Stem Cells: A Comparative Review of International Regulations
8. Human rights and ethical considerations for a tobacco-free generation
9. SNAr reactions of 5-bromo-2-chloro-4-fluoro-3-iodopyridine and its 3-substituted analogs
10. 5-Bromo-2-chloro-4-fluoro-3-iodopyridine as a Halogen-rich Intermediate for the Synthesis of Pentasubstituted Pyridines
11. Over-the-counter sales of antibiotics for human use in India: The challenges and opportunities for regulation
12. O-Heterocycle Synthesis via Intramolecular C–H Alkoxylation Catalyzed by Iron Acetylacetonate
13. How Civil Society Organisations Changed the Regulation of Clinical Trials in India
14. Trading the Genome: Investigating the Commodification of Bio-Information.
15. Enantioselective C–H Amination Catalyzed by Nickel Iminyl Complexes Supported by Anionic Bisoxazoline (BOX) Ligands
16. 5-Bromo-2-chloro-4-fluoro-3-iodopyridine as a Halogen-rich Intermediate for the Synthesis of Pentasubstituted Pyridines.
17. Efficient C–H Amination Catalysis Using Nickel-Dipyrrin Complexes
18. Using ‘smart regulation’ to tackle antimicrobial resistance in low-income and middle-income countries
19. How civil society organisations changed regulation of clinical trials in India
20. Safety of candour: how protected are apologies in open disclosure ?
21. New Hong Kong statute protects factual statements in medical apologies from use in litigation
22. Malpractice litigation in acute stroke care – where are we now?
23. Regulating clinical trials in India: The economics of ethics
24. Ethical and Regulatory Challenges with Autologous Adult Stem Cells: A Comparative Review of International Regulations
25. How Civil Society Organisations Changed the Regulation of Clinical Trials in India.
26. Regulating clinical trials in India: The economics of ethics.
27. Mason & McCall Smith’s Law & Medical Ethics
28. Review - Global Pharmaceutical Policy: Ensuring Medicines for Tomorrow’s World
29. The Medical Innovation Bill: Still more harm than good
30. Scotland the Brand – Marketing the Myth?
31. Human Embryos, Patents and Global Trade:Assessing the Scope and Contents of the TRIPS Morality Exception
32. Human Embryos, Patents and Global Trade:Assessing the Scope and Contents of the TRIPS Morality Exception
33. Preventing the selection of 'deaf embryos' under the Human Fertilisation and Embryology Act 2008: problematizing disability?
34. Oversight for Clinical Uses of Autologous Adult Stem Cells: Lessons from International Regulations
35. Global Bionetworks and Challenges in Regulating Autologous Adult Stem Cells
36. Human rights and ethical considerations for a tobacco-free generation
37. Preventing the selection of “deaf embryos” under the Human Fertilisation and Embryology Act 2008: problematizing disability?
38. Human Embryos, Patents and Global Trade: Assessing the Scope and Contents of the Trips Morality Exception
39. Book Review: Trading the Genome: Investigating the Commodification of Bio-information
40. The Regulation of Human Genetic Databases in Japan
41. The patentability of human embryonic stem cells in Europe.
42. Scotland the Brand – Marketing the Myth?
43. Clinical trials, consent, and context : the Indian experience
44. REPUBLIC 1-2.
45. Morality patently matters : the case for a universal suffrage for morally controversial biotechnological patents
46. The morality provisions in the 'European' patent system for biotechnological interventions : an institutional examination
47. Remaining rooted whilst branching out : an investigation of rules and principles in decision-making
48. Safety of candour : how protected are apologies in open disclosure?
49. Clinical trials, consent, and context: The Indian experience
50. Morality provisions in the 'European' patent system for biotechnological interventions: an institutional examination
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.